美国肝切除术后主要并发症成本:高容量中心是否具有成本效益?
该研究基于美国全国住院患者样本2002至2011年96,107例肝切除病例,估算主要并发症成本并评估高容量中心成本效益。倾向评分匹配后,主要并发症额外增加33,855美元成本、延长住院8.7天、增加死亡风险9.3%。高容量中心每例成本多5,109美元但生存延长0.54年,增量成本效益比为9,392美元。
要点
- 主要并发症额外增加33,855美元成本、延长住院8.7天、增加死亡风险9.3%。
- 常见并发症中伤口感染占3.8%成本21,995美元,呼吸衰竭占2.7%成本25,169美元。
- 高容量中心每例成本多5,109美元但生存延长0.54年,增量成本效益比9,392美元。
核心结论
- 与低容量中心相比,高容量中心实施肝切除具有成本效益。
- 肝切除术后手术部位感染、呼吸衰竭和肾衰竭对年度成本负担贡献最大。
研究设计与样本
- 利用美国全国住院患者样本回顾性分析2002至2011年96,107例肝切除病例。
- 医院按年手术量分为高容量(150例以上/年)、中等容量(51至149例/年)和低容量(1至50例/年)。
- 采用多变量回归分析确定成本预测因素,并用倾向评分匹配比较有无并发症病例的成本。
- 通过计算增量成本效益比评估高容量中心的成本效益。
主要发现
- 倾向评分匹配后,主要并发症额外增加33,855美元成本、延长平均住院8.7天(95%CI 8.4-9)、增加死亡风险9.3%(均P<0.001)。
- 常见并发症成本:伤口感染(3.8%,21,995美元)、肾衰竭(2.8%,19,201美元)、呼吸衰竭(2.7%,25,169美元)、出血(3.3%,9,180美元)。
- 成本最高但较少见的并发症:脓毒症(0.8%,33,009美元)、胃肠道出血(0.5%,32,835美元)、瘘(0.2%,27,079美元)、异物取出(0.1%,29,404美元)。
- 与低容量中心相比,高容量中心每例成本多5,109美元(95%CI 4,409-5,809,P<0.001),但平均生存延长0.54年(95%CI 0.23-0.86),增量成本效益比为9,392美元。
临床怎么用
- 肝切除术后应重点关注伤口感染、呼吸衰竭和肾衰竭的预防与管理以降低成本负担。
- 在评估医院选择时,高容量中心的较高每例成本可被生存获益所抵消,具有成本效益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of the study was to estimate the cost of major complications after liver resection and determine whether high-volume (HV) centers are cost-effective. METHODS: From 2002 to 2011, 96,107 cases of liver resection performed in the United States were identified using Nationwide Inpatient Sample. Hospitals were categorized as HV (150+ cases/yr), medium-volume (51-149 cases/yr), and low-volume (LV) (1-50 cases/yr) centers. Multivariable regression analysis identified predictors of cost. Propensity score matching comparing cases with versus without complications and costs of specific complications were estimated. Cost-effectiveness of HV centers was determined by calculating the incremental cost-effectiveness ratio. RESULTS: After propensity score matching, the occurrence of a major complication added $33,855 extra cost, increased mean length of stay by 8.7 [95% confidence interval (CI), 8.4-9] days and increased risk of death by 9.3% (all P < 0.001). The cost of most common complications was wound infection (3.8%, $21,995), renal failure (2.8%, $19,201), respiratory failure (2.7%, $25,169), and hemorrhage (3.3%, $9,180), whereas sepsis (0.8%, $33,009), gastrointestinal bleeding (0.5%, $32,835), fistula (0.2%, $27,079), and foreign body removal (0.1%, $29,404) were most costly, but less frequent. Compared with LV centers, liver resection at HV centers was associated with $5109 (95% CI, 4409-5809, P < 0.001) more cost per case, yet on average 0.54 years (95% CI, 0.23-0.86) longer survival for an incremental cost-effectiveness ratio of $9392. CONCLUSIONS: HV centers were cost-effective at performing liver resection compared with LV centers. After liver resection, complications such as surgical site infection, respiratory failure, and renal failure contributed the most to annual cost burden.
引用
- Idrees JJ, Johnston FM, Canner JK, et al. Cost of Major Complications After Liver Resection in the United States: Are High-volume Centers Cost-effective? Ann Surg. 2019. PMID: 29232212. doi:10.1097/SLA.0000000000002627
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。